(Q39030462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Fabao Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Yue Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Qian Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Yunxia Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Shuqin Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lingyi Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Xiaodong Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lihong Ye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

24 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1144-1153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464787%20AND%20SRC:MED&resulttype=core&format=json

Angiogenesis in life, disease and medicine

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Tumor angiogenesis: molecular pathways and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

FGF18 in colorectal tumour cells: autocrine and paracrine effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Fibroblast growth factors and their receptors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Increased expression of fibroblast growth factor 8 in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

HBXIP functions as a cofactor of survivin in apoptosis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Comprehensive screening for novel rab-binding proteins by GST pull-down assay using 60 different mammalian Rabs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Hypoxia-inducible factor-1 in human breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU021